Period	EPS Est.	Range	Growth	#
Current Q	$-0.01 ▲ +92.3%	$-0.01 — $-0.01	93% YoY	1
Next Q	$-0.01 ▲ +92.9%	$-0.01 — $-0.01	88% YoY	1
Current FY	$-0.05 ▲ +84.4%	$-0.05 — $-0.05	77% YoY	1
Next FY	$-0.09 ▲ +88.5%	$-0.09 — $-0.09	-13% YoY	1

Latest Reports

BULLISH 6-K 6/10

Enlivex disclosed that its RAIN token holdings were valued at approximately $1.16 billion as of May 27, 2026, representi

May 28, 2026

BULLISH 6-K 6/10

Enlivex issued a press release commenting on the Rain Foundation's $100M liquidity commitment to the Rain prediction mar

May 27, 2026

NEUTRAL Press 4/10

Enlivex announced that its RAIN token has been listed on the HTX cryptocurrency exchange (formerly Huobi), one of the to

Apr 30, 2026

Reddit Sentiment

75°

Bullish

Bearish Neutral Bullish

4 mentions 4 bullish 0 bearish

∅

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

∅

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

5 SEC filing reports analyzed. Sentiment: 2 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.

BULLISH 6-K 6/10

Enlivex disclosed that its RAIN token holdings were valued at approximately $1.16 billion as of May

May 28, 2026

BULLISH 6-K 6/10

Enlivex issued a press release commenting on the Rain Foundation's $100M liquidity commitment to the

May 27, 2026

NEUTRAL 6-K 4/10

Enlivex dosed the first U.S. patient in its Phase 2b trial of Allocetra for knee osteoarthritis, fol

May 18, 2026

BEARISH 6-K 6/10

Enlivex received a Nasdaq minimum bid price deficiency notice because its ordinary shares closed bel

May 15, 2026

NEUTRAL 6-K 3/10

Enlivex announced the launch of ENLVon, a tokenized representation of its ordinary shares on Ondo Fi

Apr 8, 2026

NEUTRAL 4/10

Enlivex announced that its RAIN token has been listed on the HTX cryptocurrency exchange (formerly H

Apr 30, 2026

BULLISH 7/10

Enlivex announced regulatory approval from Denmark's DKMA to initiate its Phase 2b trial of Allocetr

Apr 21, 2026

MIXED 6/10

Enlivex announced a $21 million convertible debt financing, a $10 million token purchase at a discou

Mar 24, 2026

Current analyst consensus: Strong Buy (86% buy). Based on 7 analysts: 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$20.00 mean target +2787.7% upside Strong Buy (3.00)

$20.00 Low $20.00 High

Metric	Value
Current Price	$0.6926
Target Low	$20.00
Target Mean	$20.00
Target Median	$20.00
Target High	$20.00
# Analysts	1
Recommendation	Strong Buy (3.00)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-03-31	$-0.01	$-0.01	$-0.01	93.3%	+92.3%	1↑ 0↓	$0.0B	0.0%	1
Next Q 2026-06-30	$-0.01	$-0.01	$-0.01	87.5%	+92.9%	1↑ 0↓	$0.0B	0.0%	1
Current FY 2026-12-31	$-0.05	$-0.05	$-0.05	77.2%	+84.4%	—	$0.0B	0.0%	1
Next FY 2027-12-31	$-0.09	$-0.09	$-0.09	-12.5%	+88.5%	—	$0.0B	0.0%	1

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$-0.010
7d ago	$-0.130	+0.120
30d ago	$-0.130	+0.120
60d ago	$-0.130	+0.120
90d ago	$-0.130	+0.120

1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Apr 7, 2026	HC Wainwright & Co.	MAINTAIN	Buy	Buy
Jan 12, 2026	HC Wainwright & Co.	MAINTAIN	Buy	Buy

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Buy %
Jun 1, 2026	2	4	1	86%
May 1, 2026	2	4	1	86%
Apr 1, 2026	2	4	2	75%
Mar 1, 2026	2	4	2	75%
Feb 1, 2026	2	4	2	75%
Jan 1, 2026	2	4	2	75%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

75°

Bullish

Bearish Neutral Bullish

4 mentions 4 bullish 0 bearish 4 time periods

Reddit Sentiment History

Date	Mentions	Sentiment	Bullish	Threads
Jun 2, 2026	1	60° Warm	1	1
Jun 2, 2026	1	60° Warm	1	1
May 28, 2026	1	60° Warm	1	1
May 28, 2026	1	60° Warm	1	1

Recent Reddit Threads

r/stocks Bullish 7d 10h ago

ENLV has $16 per share worth of RAIN tokens in the balance sheet and SP is at $0.85

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bullish 12d 14h ago

ENLV has $16 per share worth of crypto tokens in the balance sheet and SP is at $0.8

▲ 1 💬 1 ⚡ 0.3

May 25, 2026

earnings_calendar

ENLV Q1 2026 Earnings Scheduled — 2026-05-25

Apr 30, 2026

announcement

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enliv

Apr 28, 2026

announcement

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million

New acquisitions from Rain Foundation underlines Enlivex’s disciplined prediction markets treasury strategy

Apr 21, 2026

announcement

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

· Approval by the Danish Medicines Agency (DKMA) for enrolling patients in Denmark follows the recently announced FDA clearance to initiate th

Apr 8, 2026

short_volume

Short Volume: ENLV — 63.1% short (0.6M / 0.9M)

Short: 580,859 | Exempt: 0 | TRF Vol: 920,903 | Short Ratio: 63.1% | Off-exchange volume (dark pool + OTC)

Mar 30, 2026

earnings_calendar

ENLV Q4 2025 Earnings Scheduled — 2026-03-30

Mar 24, 2026

buyback

Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program

Nes-Ziona, Israel, March 24, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), a quality longevit